Streetbeat News

Equity Actions

VCNX

Vaccinex, Inc. (VCNX) announced a $3.7 million private placement for the sale of 3,838,544 shares of common stock and warrants. The proceeds, along with funds from a previous offering, are expected to fully fund the SIGNAL-AD trial for Alzheimer's treatment through Q3 2024. The company's lead drug, pepinemab, targets neurodegeneration by inhibiting SEMA4D, showing promise in Alzheimer's and Huntington's disease treatments.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:08 pm

IRON

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company, announced the appointment of Jean Franchi as Chief Financial Officer and the promotion of Jonathan Yu to Chief Operating Officer. Franchi brings over 30 years of finance leadership experience, having previously served as CFO for several biotechnology companies. She will be responsible for finance, investor relations, and leading the company's financial strategy. The company also granted Franchi an inducement equity award in line with NASDAQ Listing Rule 5635(c)(4).

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:05 pm

ALTM

Arcadium Lithium (NYSE:ALTM) has received mixed analyst ratings over the past quarter, with a significant drop in the average 12-month price target from $19.00 to $6.97. Analysts from firms like Piper Sandler, JP Morgan, and Raymond James have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Arcadium Lithium, emerging from the Allkem-Livent merger, is a key player in the lithium market, crucial for EV batteries. Despite facing revenue growth challenges, the company exhibits strong financial health indicators such as high net margin and ROE.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:01 pm

BJ

Analyst ratings for BJ's Wholesale Club (NYSE:BJ) over the past three months have been consistently indifferent, with all five analysts giving a neutral stance. The average 12-month price target has been adjusted to $67.8, down from $71.00, indicating a 4.51% decline. The company's financial performance shows positive revenue growth and strong profitability metrics, despite a high debt-to-equity ratio. Analysts from firms including Gordon Haskett, Wells Fargo, Citigroup, Roth MKM, and Evercore ISI Group have provided recent evaluations, with price targets ranging from $63.00 to $72.00.

Portfolio Pulse from Benzinga Insights

February 07, 2024 | 1:00 pm

NYCB

New York Community Bancorp has appointed Alessandro (Sandro) Dinello as its Executive Chairman, effective immediately. This strategic move aims to leverage Dinello's extensive experience in the banking sector to guide NYCB through its next phase of growth and development.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:48 pm

TIPT

Fortegra Group, a subsidiary of Tiptree Inc. (TIPT), has decided to withdraw its planned initial public offering (IPO) due to the current market conditions. This decision reflects the company's assessment of the market environment and its potential impact on the IPO's success.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:48 pm

PEPG

PepGen announced the pricing of its offering of 7.53 million shares at $10.635 each, expecting to raise approximately $80.1 million before fees and expenses.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:39 pm

HUT

Hut 8 Corp announced the immediate departure of CEO Jaime Leverton and appointed Asher Genoot as the new CEO. This change follows the completion of the company's merger of equals, signaling a new strategic direction.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:31 pm

PHUN

Phunware has announced a public offering to sell shares of its common stock, though specific details of the offering were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:18 pm

CDW

CDW has announced a $750M increase to its share repurchase program. Over the past year, the company repurchased 2.6 million shares for about $358.7 million and acquired 168,464 shares for $23.5 million from employees as part of employee equity awards.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 12:10 pm